From October 1, 2022 to December 31, 2022, the company has repurchased 116,201 shares, representing 0.02% for CNY 2.21 million. With this, the company has completed the repurchase of 988,501 shares, representing 0.13% for CNY 18.93 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.66 CNY | -4.44% |
|
+1.21% | -2.13% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.13% | 2.81B | |
+6.96% | 98.81B | |
+8.29% | 42.32B | |
-11.77% | 34.48B | |
+82.32% | 29.83B | |
-11.30% | 15.93B | |
+1.16% | 14.01B | |
-12.13% | 11.52B | |
+176.65% | 10.45B | |
+6.74% | 9.06B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.